Literature DB >> 8954574

Molecular cloning and kinetic characterization of a flavin-containing monooxygenase from Saccharomyces cerevisiae.

J K Suh1, L L Poulsen, D M Ziegler, J D Robertus.   

Abstract

An open reading frame from yeast coding for a homologue of flavin containing monooxygenase (FMO) has been cloned into several Escherichia coli expression vectors. A His10 peptide attached to the amino terminus produced a high yield of soluble protein when coexpressed with GroEL and GroES. The protein was purified on an affinity column and characterized. The protein binds one mole per mole of flavin but the binding is relatively weak and 50 microM exogenous FAD is used to maintain full occupancy. The yeast enzyme, like mammalian enzymes, exhibits NADPH oxidase activity. The enzyme does not catalyze the oxidation of amines, but thiols, including glutathione, cysteine, and cysteamine, show substrate activity. The Km values for these are 7.0, 9.9, and 1.3 mM, respectively; kcat values are 94, 246, and 94 per min, respectively. The enzyme apparently does not accept xenobiotic compounds but may be involved in maintaining cellular reducing potential, probably through its action on cysteamine. This activity may represent the initial role of the FMO family of enzymes, giving rise to the multigene family of drug metabolizing enzymes seen in modern mammals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954574     DOI: 10.1006/abbi.1996.0557

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  Bacterial flavin-containing monooxygenase is trimethylamine monooxygenase.

Authors:  Yin Chen; Nisha A Patel; Andrew Crombie; James H Scrivens; J Colin Murrell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

2.  Molecular and biochemical characterization of the xlnD-encoded 3-hydroxybenzoate 6-hydroxylase involved in the degradation of 2,5-xylenol via the gentisate pathway in Pseudomonas alcaligenes NCIMB 9867.

Authors:  Xiaoli Gao; Chew Ling Tan; Chew Chieng Yeo; Chit Laa Poh
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

3.  Mechanism of action of a flavin-containing monooxygenase.

Authors:  Subramaniam Eswaramoorthy; Jeffrey B Bonanno; Stephen K Burley; Subramanyam Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-15       Impact factor: 11.205

Review 4.  Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes.

Authors:  Ryan Rossner; Matt Kaeberlein; Scott F Leiser
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

5.  Yeast flavin-containing monooxygenase is induced by the unfolded protein response.

Authors:  J K Suh; J D Robertus
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 6.  Regulated methionine oxidation by monooxygenases.

Authors:  Bruno Manta; Vadim N Gladyshev
Journal:  Free Radic Biol Med       Date:  2017-02-14       Impact factor: 7.376

7.  Yeast flavin-containing monooxygenase generates oxidizing equivalents that control protein folding in the endoplasmic reticulum.

Authors:  J K Suh; L L Poulsen; D M Ziegler; J D Robertus
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

8.  Revealing the moonlighting role of NADP in the structure of a flavin-containing monooxygenase.

Authors:  Andrea Alfieri; Enrico Malito; Roberto Orru; Marco W Fraaije; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

9.  Characterization of the flavin monooxygenase involved in biosynthesis of the antimalarial FR-900098.

Authors:  Kim Nguyen; Matthew A DeSieno; Brian Bae; Tyler W Johannes; Ryan E Cobb; Huimin Zhao; Satish K Nair
Journal:  Org Biomol Chem       Date:  2019-02-06       Impact factor: 3.876

Review 10.  Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives.

Authors:  Irfan M Hisamuddin; Vincent W Yang
Journal:  Pharmacogenomics       Date:  2007-06       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.